GlaxoSmithKline  logo
GSKGlaxoSmithKline
Trade GSK now
GlaxoSmithKline  primary media

About GlaxoSmithKline

GlaxoSmithKline (LSE:GSK), (NYSE:GSK) is a global healthcare company engaged in the research, development, and manufacturing of pharmaceutical medicines, vaccines, and consumer healthcare products. The company operates across a broad spectrum of therapeutic areas including respiratory diseases, HIV, immune-inflammation, and oncology. GSK is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. The company's objectives are geared towards innovation in the medical field, ensuring the accessibility of its products, and leveraging scientific and technical expertise to address unmet medical needs. GSK's projects span from drug discovery and development to sustainable business practices, emphasizing its role in global healthcare.

What is GSK known for?

Snapshot

Public US
Ownership
2000
Year founded
102759
Employees
Brentford, United Kingdom
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

Produtos e/ou serviços de GlaxoSmithKline

  • Global healthcare giant provides a vast line of prescription medicines, covering areas from asthma to infections.
  • A world leader in vaccines, protecting individuals from illnesses like hepatitis and rotavirus.
  • Diverse consumer healthcare catalog includes oral hygiene staples, over-the-counter medicines, and nutritional products.
  • Undertakes innovative research and development projects to discover new pharmaceuticals, vaccines, and consumer healthcare products.
  • Clinical trials play a significant role, ensuring the safety and effectiveness of its wide-ranging products.
  • Hierarchically collaborated partnerships straddle academia, biotech firms, and peer companies, to fast-track pharmaceutical research and development.

equipe executiva do GlaxoSmithKline

  • Ms. Julie Belita Brown A.C.A.CFO & Executive Director
  • Dr. Jesse L. Goodman M.D., M.P.H.Scientific & Medical Expert
  • Mr. Luke Victor MielsChief Executive Officer & Director
  • Ms. Shobie RamakrishnanChief Digital & Technology Officer
  • Mr. Tony WoodChief Scientific Officer and Head of R&D
  • Mr. Constantin FestSenior VP & Head of Investor Relations
  • Mr. James FordSenior VP & Group General Counsel of Legal & Compliance
  • Mr. David Simon Redfern BSc (Hons), CAPresident of Corporate Development
  • Ms. Diana ConradChief People Officer
  • Mr. Philip C. ThomsonPresident of Global Affairs

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.